Things certainly are wacky these days. The Fighting Illini football team has won four Big Ten games in a row becoming bowl eligible. Our beloved Chicago Bears finally won a football game. Livongo seems to have found some life, Dexcom is blazing hot, Insulet is on fire while Tandem and Abbott continue to wait for the FDA to do its thing.
One of the things we wonder about given the competitive landscape is whether or not Medtronic will reconsider spinning off their struggling diabetes franchise or will they attempt to fix the many issues this unit faces. Now under new . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.